Species

Organizations

Refine Search

Species

Canine

Feline

Equine

Bovine

Organizations

University of Guelph

ACI

Anivive Lifesciences

Midwestern University

University of Florida

Cornell

All Studies (6)

Showing 1-6 of 6 Trials

University of Florida

•Canine

•Cardiovascular

•Interventional

•1 Location

DCM in Dobermans

University of Florida

•Canine

•Cardiovascular

•Interventional

•1 Location

Dilated Cardiomyopathy (DCM) is a disease of heart muscle that results in a decreased ability of the heart to pump blood. The prognosis for DCM is often poor, with a less than 50% survival rate one year after clinical signs develop, unless a reversible underlying cause is identified. There is no available cure for Dilated Cardiomyopathy, current techniques focus on extending survival time as long as possible. However the focus of this clinical trial is to evaluate a potential curative treatment for cardiomyopathy in the Doberman Pinscher.

Your dog has been diagnosed with dilated cardiomyopathy

A diagnosis of DCM and previous evidence of congestive heart failure which has been controlled with medical management.
A circulating neutralizing antibody titer to the virus vector of less than 1:20
Owner agreement to authorize participation with informed consent and collection of the heart following euthanasia or death from any cause.

Your dog has no other heart conditions

Clear of extra-cardiac disease, congenital heart disease or primary mitral valvular disease

Cornell

•Canine

•Interventional

•1 Location

Selective Inhibition of Nuclear Export (SINE) and Canine Osteosarcoma

Cornell

•Canine

•Interventional

•1 Location

Osteosarcoma is a common cancer diagnosed in dogs, particularly in large breed dogs. While several chemotherapy protocols have been shown to provide modest management of the onset of metastasis (spread of cancer), we are continuously looking for additional treatments that may extend survival time. Carboplatin is a widely accepted chemotherapy agent used in treatment of osteosarcoma. The results of this study will allow us to determine if dogs can successfully tolerate carboplatin and a new drug called Laverdia-CA1 (verdinexor) in a combination protocol.

Selective Inhibition of Nuclear Export (SINE) and Canine Osteosarcoma

Your dog has been seen by CUHA

Patients must have been previously treated at Cornell University Hospital for Animals

Your dog has had limb amputation due to osteosarcoma

Patients must had been diagnosed with osteosarcoma and had limb amputation at Cornell University Hospital for Animals previously.

You dog has NOT received any chemotherapy

Patients must not have received chemotherapy treatment previously

Midwestern University

•Canine

•Observational

•1 Location

Performance of a New Point-of-care Rapid Test to Diagnose Pulmonary Coccidioidomycosis

Midwestern University

•Canine

•Observational

•1 Location

Diagnosis of coccidioidomycosis in dogs is challenging due to the fact that the symptoms are not specific for this disease. Coccidioidomycosis can be diagnosed via a biopsy however the most common method is testing for antibodies to the fungus. These tests are often sent to third party labs delaying confirmation of the disease. This study looks to evaluate a potential point of care rapid test which would be able to provide a positive or negative result indicating the presence or absence of antibodies, respectively, within 30-60 minutes. The diagnosis of pulmonary coccidioidomycosis can be difficult because clinical signs overlap with many other respiratory tract disorders and dogs can have positive Valley Fever antibody titers without active clinical infection. Acute phase proteins are useful biomarkers for many other disorders and our hope is to determine whether they can facilitate making a diagnosis of pulmonary coccidioidomycosis in dogs. For additional details or questions please contact Dr. Jaffey ([email protected]).

Performance of a New Point-of-care Rapid Test to Diagnose Pulmonary Coccidioidomycosis

Your dog has a a confirmed or suspected novel diagnosis of pulmonary coccidioidomycosis

Your dog has at least 1 respiratory sign

Your dog has one of the following respiratory signs:

Cough
Exercise intolerance
Wheezing
Dyspnea
Tachypnea
Respiratory distress

Your dog has not received an anti-fungal treatment more than 7 days before enrollment

Dog must not have received an anti-fungal treatment for more than 7 days before enrollment

Midwestern University

•Canine

•Interventional

•1 Location

Efficacy of twice-daily nebulized budesonide for the treatment of canine chronic bronchitis and eosinophilic lung disease

Midwestern University

•Canine

•Interventional

•1 Location

Canine chronic bronchitis and eosinophilic lung disease are inflammatory diseases characterized by cough for > 2 months without another identifiable cause. Dogs with chronic bronchitis have persistent airway neutrophilic inflammation. The foundation of long-term therapy is corticosteroids. Oral prednisone is commonly used but has a litany of possible adverse effects. Inhaled steroids is an alternative to avoid the adverse effects of prednisone but the only available option is fluticasone. This medication is expensive and has variable efficacy. Inhaled budesonide is a medication used in humans to treat a similar airway disorder and is a fraction of the cost. This study aims to investigate the benefit of inhaled budesonide on respiratory tract symptoms in dogs with inflammatory airway disorders.

Efficacy of twice-daily nebulized budesonide for the treatment of canine chronic bronchitis and eosinophilic lung disease

Your dog has a chronic cough for longer than 2 months.

Dogs with a history of cough exceeding two months may be eligible for the study.

Your dog has thoracic radiographs performed in the past 3.

Thoracic radiographs will be used by principal investigator to determine eligibility.

Your dog does NOT have an alternative cause for chronic cough.

Dogs with alternative caused for chronic cough such as tracheal collapse, heart disease, cancer, Valley Fever, etc are not eligible for this study.

Your dog is NOT currently receiving treatment with corticosteroids.

Dogs who are currently receiving corticosteroids for treatment will be given consideration if they discontinue treatment before enrollment.

Cornell

•Canine

•Oncology

•Interventional

•1 Location

Helping More Dogs with Lymphoma

Cornell

•Canine

•Oncology

•Interventional

•1 Location

Lymphoma is one of the most common cancers in dogs with few treatment options available. Traditional injectable chemotherapeutic drugs have been used to extend quality of life, achieve clinical remissions, and slow cancer progression, but are not feasible options for many families. Additional safe, low cost therapies are needed for canine patients. Multi-agent chemotherapy plus prednisone (an oral steroid pill) is the standard treatment. However, this is not a viable option for many families with affected dogs. Cyclophosphamide is also given by mouth, inexpensive, and part of the standard of care chemotherapy protocol for dogs with lymphoma, but it's effectiveness as a single agent has not been well-studied or reported. We want to learn about what happens when prednisone, an antibiotic, and cyclophosphamide are used together. Our goal is to develop a well-tolerated, effective, oral chemotherapy protocol as an alternative for families that want to avoid injectable chemotherapy.

Dogs seen by the Cornell University Hospital for Animals who have been diagnosed with large cell lymphoma or cutaneous lymphoma who are not already on oral prednisone. Diagnosis can be confirmed at the initial study visit if needed. Dogs must have at least one enlarged (>2cm diameter), peripheral lymph node for large cell lymphoma.

Cornell

•Canine

•Cardiovascular

•Observational

•1 Location

Studying Electrophysiology of the Sinus Node in Dogs who Need Pacemakers

Cornell

•Canine

•Cardiovascular

•Observational

•1 Location

The sinus node is the major pacemaker of the heart. In dogs, disease of the sinus node can result in slow heart rates that requires pacemaker implantation. The goal of this study is to characterize the electrical properties of the sinus node in dogs with slow heart rates that require pacemakers.

Studying Electrophysiology of the Sinus Node in Dogs who Need Pacemakers

Any dog seen at the Cornell University Hospital for Animals with a diagnosis of a slow heart rate that requires pacemaker implantation.

Species

Organizations

Categories

Refine Search

Species

Organizations

Categories

All Studies (6)

DCM in Dobermans

Selective Inhibition of Nuclear Export (SINE) and Canine Osteosarcoma

Performance of a New Point-of-care Rapid Test to Diagnose Pulmonary Coccidioidomycosis

Efficacy of twice-daily nebulized budesonide for the treatment of canine chronic bronchitis and eosinophilic lung disease

Helping More Dogs with Lymphoma

Studying Electrophysiology of the Sinus Node in Dogs who Need Pacemakers

Recommended from Anivive

Performance of a New Point-of-care Rapid Test to Diagnose Pulmonary Coccidioidomycosis

Efficacy of twice-daily nebulized budesonide for the treatment of canine chronic bronchitis and eosinophilic lung disease

Helping More Dogs with Lymphoma

Studying Electrophysiology of the Sinus Node in Dogs who Need Pacemakers

RESOURCES

CONTACT US